NCT00948220 Influence of Antiviral Therapy on Bone Mineral Density and Metabolism in Patients With Chronic Hepatitis C Status COMPLETED Phase PHASE4
NCT00943826 A Study of Bevacizumab (Avastin®) in Combination With Temozolomide and Radiotherapy in Participants With Newly Diagnosed Glioblastoma Status COMPLETED Phase PHASE3
NCT00940875 A Study of Tarceva (Erlotinib) in Sequential Combination With Gemcitabine as First Line Therapy in Patients With Advanced Non-Small Cell Lung Cancer Status TERMINATED Phase PHASE2
NCT00940628 A Study of Xenical (Orlistat) in Overweight and Obese Adolescents Status COMPLETED Phase PHASE3
NCT00940485 A Study of Combination or Sequential Treatment With PEGASYS (Peginterferon Alfa-2a) and Entecavir in Patients With HBeAg Positive Chronic Hepatitis B Status COMPLETED Phase PHASE4
NCT00940420 A Study of Combination Treatment With Pegasys (Peginterferon Alfa) and Copegus (Ribavirin)in Patients With Chronic Hepatitis C Status COMPLETED Phase PHASE4
NCT00940303 OPAL Study: A Study of Avastin (Bevacizumab) in Combination With FOLFOXIRI in Patients With Previously Untreated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00937729 Prospective Evaluation Among Patients Infected by HIV 1 in Virological Failure Owing to Lack of Compliance, of the Benefit in Terms of Compliance of an Optimised Antiretroviral Treatment With Enfuvirtide (Fuzeon) Associated With Two Active Molecules Status TERMINATED Phase N/A
NCT00937560 A Study of First Line Treatment With Avastin (Bevacizumab) in Combination With Carboplatin and Weekly Paclitaxel in Patients With Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00934856 A Study of Trastuzumab Emtansine (T-DM1) in Combination With Docetaxel, and Potentially Pertuzumab, in Participants With Advanced Breast Cancer Status COMPLETED Phase PHASE1/PHASE2
NCT00934648 A Study of MabThera (Rituximab) in Patients With Rheumatoid Arthritis Who Have Had an Inadequate Response to Methotrexate Status COMPLETED Phase PHASE4
NCT00933972 A Study of RO4998452 in Type 2 Diabetes Patients With Varying Degrees of Renal Impairment Status COMPLETED Phase PHASE1
NCT00932971 HIDIT II - PegIFN-alfa2a Plus Tenofovir in Chronic Delta Hepatitis Status COMPLETED Phase PHASE2
NCT00930514 A Pharmacokinetic Study of Subcutaneous and Intravenous Rituximab in Participants With Follicular Lymphoma Status COMPLETED Phase PHASE1
NCT00929240 A Study of Avastin (Bevacizumab) + Xeloda (Capecitabine)as Maintenance Therapy in Patients With HER2-Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE3
NCT00927082 A Follow-Up Study to WV19432, to Evaluate Long Term Post-Treatment Effects of PEGASYS (Peginterferon Alfa-2a(40KD))in Patients With HBeAg Positive Chronic Hepatitis B Status COMPLETED Phase PHASE4
NCT00925769 ATX Study:A Study of Avastin (Bevacizumab), Tarceva (Erlotinib) and Xeloda (Capecitabine) in Patients With Locally Advanced and/or Metastatic Pancreatic Cancer Status COMPLETED Phase PHASE1
NCT00922779 A Study of Ribavirin in Combination With PEGASYS (Peginterferon Alfa-2a (40KD))in Patients With Chronic Hepatitis C Status COMPLETED Phase PHASE4
NCT00922610 A Study of Mircera in Renal Anemia Among Filipino Chronic Kidney Disease Patients Status COMPLETED Phase PHASE4
NCT00922207 A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Adefovir or Entecavir in Patients With HBeAg-Positive Chronic Hepatitis B Status COMPLETED Phase PHASE4